脊灰疫苗:世界卫生组织立场文件,2016年3月——建议
本文摘录世界卫生组织2016年3月脊灰疫苗立场文件中的脊灰疫苗使用建议,该文件取代2014年立场文件。文件总结世界卫生组织关于将至少一剂灭活脊灰疫苗(IPV)纳入常规免疫规划的立场,以减轻停用口服脊灰疫苗(OPV)中Sabin 2型株后2型脊灰潜在再现的风险,并反映2016年4月全球从三价OPV向二价OPV的转换。
要点
- 世界卫生组织2016年3月立场文件建议将至少一剂灭活脊灰疫苗(IPV)纳入常规免疫规划。
- 该策略旨在减轻停用口服脊灰疫苗中Sabin 2型株后2型脊灰潜在再现的风险。
- 该立场文件反映2016年4月全球从三价口服脊灰疫苗向二价口服脊灰疫苗的转换。
核心结论
- 世界卫生组织立场文件总结关于将至少一剂灭活脊灰疫苗(IPV)纳入常规免疫规划的立场,以减轻停用口服脊灰疫苗中Sabin 2型株后2型脊灰潜在再现的风险。
研究设计与样本
- 本文为世界卫生组织2016年3月脊灰疫苗立场文件的建议摘录,该立场文件取代2014年世界卫生组织立场文件。
关键数值与推荐
- 世界卫生组织立场文件建议将至少一剂灭活脊灰疫苗(IPV)纳入常规免疫规划。
- 该立场文件反映2016年4月全球从三价口服脊灰疫苗向二价口服脊灰疫苗的转换。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This article presents the World Health Organization's (WHO) recommendations on the use of polio vaccine excerpted from the WHO position paper on polio vaccines - March 2016, published in the Weekly Epidemiological Record [1]. This position paper on polio vaccines replaces the 2014 WHO position paper [2]. The position paper summarizes the WHO position on the introduction of at least one dose of inactivated polio vaccine (IPV) into routine immunization schedules as a strategy to mitigate the potential risk of re-emergence of type 2 polio following the withdrawal of Sabin type 2 strains from oral polio vaccine (OPV) [3]. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This position paper reflects the global switch from trivalent to bivalent OPV which took place in April 2016. Recommendations on the use of polio vaccines have been discussed on multiple occasions by SAGE, most recently in October 2016; evidence presented at these meetings can be accessed at: http://www.who.int/immunization/sage/previous/en/index.html.
引用
- World Health Organization. Polio vaccines: WHO position paper, March 2016-recommendations. Vaccine. 2016. PMID: 27894720. doi:10.1016/j.vaccine.2016.11.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。